A detailed history of Vanguard Group Inc transactions in Schrodinger, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,809,024 shares of SDGR stock, worth $147 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,809,024
Previous 6,776,631 0.48%
Holding current value
$147 Million
Previous $243 Million 24.22%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$24.74 - $35.13 $801,402 - $1.14 Million
32,393 Added 0.48%
6,809,024 $184 Million
Q4 2023

Feb 14, 2024

BUY
$21.62 - $37.21 $1.68 Million - $2.9 Million
77,830 Added 1.16%
6,776,631 $243 Million
Q3 2023

Nov 14, 2023

BUY
$27.34 - $55.37 $792,340 - $1.6 Million
28,981 Added 0.43%
6,698,801 $189 Million
Q2 2023

Aug 14, 2023

BUY
$26.1 - $49.92 $38.5 Million - $73.7 Million
1,475,576 Added 28.41%
6,669,820 $333 Million
Q1 2023

May 15, 2023

BUY
$18.09 - $27.61 $1.34 Million - $2.04 Million
73,895 Added 1.44%
5,194,244 $137 Million
Q4 2022

Feb 10, 2023

BUY
$16.24 - $26.38 $1.04 Million - $1.68 Million
63,870 Added 1.26%
5,120,349 $95.7 Million
Q3 2022

Nov 14, 2022

BUY
$23.95 - $34.71 $2.68 Million - $3.89 Million
112,074 Added 2.27%
5,056,479 $126 Million
Q2 2022

Aug 12, 2022

BUY
$21.39 - $35.9 $4 Million - $6.71 Million
186,971 Added 3.93%
4,944,405 $131 Million
Q1 2022

May 13, 2022

SELL
$24.84 - $36.12 $1.43 Million - $2.08 Million
-57,624 Reduced 1.2%
4,757,434 $162 Million
Q4 2021

Feb 14, 2022

BUY
$33.38 - $59.25 $1.46 Million - $2.58 Million
43,608 Added 0.91%
4,815,058 $168 Million
Q3 2021

Nov 12, 2021

BUY
$53.75 - $76.55 $8.33 Million - $11.9 Million
154,898 Added 3.36%
4,771,450 $261 Million
Q2 2021

Aug 13, 2021

BUY
$59.02 - $78.8 $272 Million - $364 Million
4,616,552 New
4,616,552 $349 Million

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.33B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.